INSM

Insmed Incorporated

75.01 USD
-0.05 (-0.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Insmed Incorporated stock is up 14.38% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 48% of the previous 24 July’s closed higher than June. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
18 Jul 18:29 19 Jul, 2024 45.00 CALL 13 23741
18 Jul 18:42 19 Jul, 2024 45.00 CALL 12 23741
18 Jul 18:43 19 Jul, 2024 45.00 CALL 71 23741
18 Jul 18:46 19 Jul, 2024 45.00 CALL 117 23741
18 Jul 18:55 19 Jul, 2024 45.00 CALL 99 23741
18 Jul 18:55 19 Jul, 2024 45.00 CALL 48 23741
18 Jul 18:56 19 Jul, 2024 45.00 CALL 10 23741
18 Jul 18:59 19 Jul, 2024 45.00 CALL 140 23741
18 Jul 19:26 17 Jan, 2025 80.00 PUT 32 2
18 Jul 19:30 19 Jul, 2024 30.00 CALL 6 16695

About Insmed Incorporated

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1.

  • Guggenheim
    Tue Jul 9, 12:22
    buy
    confirm
  • HC Wainwright & Co.
    Mon Jul 8, 06:34
    buy
    confirm
  • Bank of America
    Fri Jul 5, 09:21
    buy
    confirm
  • HC Wainwright & Co.
    Tue Jul 2, 06:37
    buy
    confirm
  • Truist Securities
    Mon Jul 1, 08:48
    buy
    confirm
  • Bank of America
    Fri Jun 28, 10:50
    buy
    confirm
  • Evercore Partners
    Fri Jun 21, 12:42
    buy
    confirm
  • Cantor Fitzgerald
    Thu Jun 20, 13:36
    buy
    confirm
  • JP Morgan
    Thu Jun 20, 09:04
    buy
    confirm